ATE353912T1 - Peptizusammensetzung für die mundhöhle - Google Patents

Peptizusammensetzung für die mundhöhle

Info

Publication number
ATE353912T1
ATE353912T1 AT04030053T AT04030053T ATE353912T1 AT E353912 T1 ATE353912 T1 AT E353912T1 AT 04030053 T AT04030053 T AT 04030053T AT 04030053 T AT04030053 T AT 04030053T AT E353912 T1 ATE353912 T1 AT E353912T1
Authority
AT
Austria
Prior art keywords
oral cavity
composition
peptistic
formation
tyr gln
Prior art date
Application number
AT04030053T
Other languages
English (en)
Inventor
Hidenobu Senpuku
Yumiko Masuzawa
Junichi Okada
Original Assignee
G C Dental Ind Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G C Dental Ind Corp filed Critical G C Dental Ind Corp
Application granted granted Critical
Publication of ATE353912T1 publication Critical patent/ATE353912T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
AT04030053T 2003-12-19 2004-12-17 Peptizusammensetzung für die mundhöhle ATE353912T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003422472A JP2005179268A (ja) 2003-12-19 2003-12-19 口腔用組成物

Publications (1)

Publication Number Publication Date
ATE353912T1 true ATE353912T1 (de) 2007-03-15

Family

ID=34697330

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04030053T ATE353912T1 (de) 2003-12-19 2004-12-17 Peptizusammensetzung für die mundhöhle

Country Status (5)

Country Link
US (1) US7094759B2 (de)
EP (1) EP1564218B1 (de)
JP (1) JP2005179268A (de)
AT (1) ATE353912T1 (de)
DE (1) DE602004004754T2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101938990A (zh) * 2008-02-08 2011-01-05 高露洁-棕榄公司 包含碱性氨基酸肽和蛋白酶的组合物和方法
EP3384938A1 (de) 2011-09-12 2018-10-10 Moderna Therapeutics, Inc. Manipulierte nukleinsäuren und verfahren zur verwendung davon
EP2834259A4 (de) 2012-04-02 2016-08-24 Moderna Therapeutics Inc Modifizierte polynukleotide
HK1206612A1 (en) 2012-04-02 2016-01-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of secreted proteins
EP3374391B1 (de) 2015-11-10 2024-04-17 Visterra, Inc. Antikörpermolekülarzneimittelkonjugate die an lipopolysaccharide binden und verwendungen davon
KR102322170B1 (ko) * 2016-02-26 2021-11-08 (주)오케이바이오 치약조성물
JP7303110B2 (ja) 2017-01-18 2023-07-04 ビステラ， インコーポレイテッド 抗体分子－薬物コンジュゲートおよびその使用
BR112021018439A2 (pt) 2019-03-18 2021-11-23 Sunstar Americas Inc Composição para higiene bucal
CN114760976A (zh) 2019-12-16 2022-07-15 高露洁-棕榄公司 含有菊粉的口腔护理组合物
US11969476B2 (en) 2020-04-03 2024-04-30 Visterra, Inc. Antibody molecule-drug conjugates and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816563A (en) * 1983-11-25 1989-03-28 Amtron, Inc. Process for obtaining transfer factor from colostrum, transfer factor so obtained and use thereof
ZA878295B (en) * 1986-11-06 1988-05-03 Amarillo Cell Culture Co. Inc. Treatment of immuno-resistant disease
CA2106609A1 (en) 1992-09-28 1994-03-29 Irene Yeatman Aldridge Proteases to inhibit and remove biofilm
JP2002114709A (ja) 2000-10-04 2002-04-16 Univ Nihon 虫歯予防剤
JP2002284604A (ja) 2001-03-29 2002-10-03 Shiseido Co Ltd 抗菌防黴助剤
JP2002302404A (ja) 2001-04-02 2002-10-18 Shiseido Co Ltd 抗菌防黴助剤

Also Published As

Publication number Publication date
DE602004004754T2 (de) 2007-12-06
US20050180928A1 (en) 2005-08-18
US7094759B2 (en) 2006-08-22
EP1564218B1 (de) 2007-02-14
EP1564218A1 (de) 2005-08-17
DE602004004754D1 (de) 2007-03-29
JP2005179268A (ja) 2005-07-07

Similar Documents

Publication Publication Date Title
EP2085096A3 (de) Neuartige Zusammensetzung und Verfahren zur Behandlung von Immunerkrankungen
MX2007002669A (es) Reactivos de superficie corporal basados en peptidos, para el cuidado personal.
HUP0401124A2 (hu) VII koagulációs faktor származékok
BR0214705A (pt) Composição, seu uso, método para prevenção ou tratamento de doença neurodegenerativa, e kit
BRPI0407662A (pt) derivados do ácido 1-fenilalcanocarboxìlico para o tratamento de doenças neurodegenerativas
DE602004022200D1 (de) Mund- und körperpflegezusammensetzungen und verfahren
ATE353912T1 (de) Peptizusammensetzung für die mundhöhle
EP1614675A3 (de) Aminosäuren mit affinität zu alpha2-delta-protein
ATE359053T1 (de) Dentalmaterial gegen karies
MXPA05008704A (es) Proteinas de fusion de muteinas de interferon alfa con propiedades mejoradas.
CY1107342T1 (el) Χρηση παραγωγων νιτριλιου ως φαρμακο
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
BRPI0707420A8 (pt) composições contendo peptídeos com aminoácidos e métodos não naturais do uso
AU2003303076A1 (en) Cathepsin cysteine protease inhibitors and their use
WO2004024077A3 (en) Novel composition and methods for the treatment of psoriasis
WO2022043273A3 (en) Oral care composition comprising a fructanase
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
BRPI0509667A (pt) azaquinazolinas substituìdas com eficácia antiviral
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
WO2003083472A1 (en) Method of judging risk of peiodontal disease
WO2004039409A3 (de) Zusammensetzung enthaltend aktivatoren von ik-kaliumkanälen und calcineurin-antagonisten und deren verwendung
DE602004026840D1 (de) Physiologisch aktive peptide und medikamente, die diese enthalten
DE60331166D1 (de) Splice variante des menschlichen hypophysären wachstumshormons
IL174134A0 (en) Use of a protein in the preparation of a medicament for treatment of fibrotic diseases

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties